Immuneering
IMRX
IMRX
68 hedge funds and large institutions have $182M invested in Immuneering in 2025 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
74% more funds holding
Funds holding: 39 → 68 (+29)
52% more ownership
Funds ownership: 10.64% → 62.65% (+52%)
Holders
68
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$44.5M | |
| 2 | +$14.1M | |
| 3 | +$9.34M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$7.87M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.05M |
Top Sellers
| 1 | -$1.57M | |
| 2 | -$143K | |
| 3 | -$99.1K | |
| 4 |
First Manhattan
New York
|
-$41.9K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$18.2K |
